High integrity storage of larger sample volumes
Micronic has expanded its range of high quality 4.00 mL sample storage tubes to now include non-coded, alphanumeric and 2D data matrix coded formats.
Offering a working volume of 2.70 mL these tubes provide an ideal solution for storing larger volumes in a wide variety of short-term and long-term sample storage applications. Incorporating an internal thread screw cap with silicon O-ring, Micronic 4.00 mL tubes provide optimal sealing enabling high integrity storage at ultra-low temperatures. Benefiting from a flat bottom, Micronic 4.00 mL tubes also provide an ideal solution for transportation or storage of solid biological samples.
Precision manufactured from ultra-pure grade polypropylene, in a certified Class 7 clean room production environment, Micronic 4.00 mL tubes are available in bulk and in automation-compatible Micronic 48-4 Racks. This 48-well format rack features a laser etched 1D rack barcode on one side and 'Twist-Lock' to prevent tubes from turning during screw capping or decapping.
Micronic 4.00 mL tubes with a 2D Data-Matrix code permanently laser-etched on the bottom of the tube are the storage medium of choice for customers demanding long-term reliable code reading. The 4.00ml alphanumeric tubes are a great option for customers who just need to identify their samples visually. For labs requiring larger volume storage in a top quality tube, Micronic 4.00 mL non-coded tubes provide a cost-competitive solution.
To enhance visual identification of samples - Micronic screw caps for 4.00 mL tubes are available in 12 colours. In addition, Micronic screw caps are designed to be closed with a 'single turn' to ease opening and closure during manual processing.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.